Literature DB >> 25999299

Occurrence and new mutations involved in rifampicin-resistant Propionibacterium acnes strains isolated from biofilm or device-related infections.

Ulrika Furustrand Tafin1, Guillaume Ghislain Aubin2, Gerhard Eich3, Andrej Trampuz4, Stéphane Corvec5.   

Abstract

We described for the first time the amino acid substitutions conferring rifampicin resistance in eight Propionibacterium acnes strains isolated from patients with biofilm or device-related infections. We identified different mutations in cluster I and one mutation, never reported, in cluster II of the rpoB gene (I480V) associated with the most frequent one in cluster I (S442L). Half of the patients previously received treatment with rifampicin.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biofilm; Foreign-body infection; Propionibacterium acnes; Resistance; Rifampicin

Mesh：

Substances：

Year:  2015        PMID： 25999299     DOI： 10.1016/j.anaerobe.2015.05.003

Source DB:  PubMed          Journal:  Anaerobe        ISSN： 1075-9964            Impact factor:   3.331


  9 in total

1.  Assessment of the Potential for Inducing Resistance in Multidrug-Resistant Organisms from Exposure to Minocycline, Rifampin, and Chlorhexidine Used To Treat Intravascular Devices.

Authors:  Joel Rosenblatt; Nylev Vargas-Cruz; Ruth A Reitzel; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  Unusual Case of Spondylodiscitis due to Listeria monocytogenes.

Authors:  Guillaume Ghislain Aubin; David Boutoille; Romain Bourcier; Jocelyne Caillon; Didier Lepelletier; Pascale Bémer; Stéphane Corvec
Journal:  J Bone Jt Infect       Date:  2016-02-29

3.  Propionibacterium acnes and Staphylococcus epidermidis olecranon bursitis/osteomyelitis: a case involving surgical and antibiotic treatment.

Authors:  John G Skedros; Micheal G Adondakis; Eric M Brown; Marquam R Oliver
Journal:  BMJ Case Rep       Date:  2018-02-12

4.  Rifampin-Resistant Cutibacterium (formerly Propionibacterium) namnetense Superinfection after Staphylococcus aureus Bone Infection Treatment.

Authors:  Stéphane Corvec; Aurélie Guillouzouic; Guillaume Ghislain Aubin; Sophie Touchais; Olivier Grossi; François Gouin; Pascale Bémer
Journal:  J Bone Jt Infect       Date:  2018-11-24

5.  Orthopedic implant-associated infections caused by Cutibacterium spp. - A remaining diagnostic challenge.

Authors:  Nora Renz; Stasa Mudrovcic; Carsten Perka; Andrej Trampuz
Journal:  PLoS One       Date:  2018-08-20       Impact factor: 3.240

Review 6.  The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review.

Authors:  Ruth A Reitzel; Joel Rosenblatt; Bahgat Z Gerges; Andrew Jarjour; Ana Fernández-Cruz; Issam I Raad
Journal:  JAC Antimicrob Resist       Date:  2020-02-21

7.  Draft Genome Sequence of Highly Rifampin-Resistant Propionibacterium namnetense NTS 31307302T Isolated from a Patient with a Bone Infection.

Authors:  Guillaume Ghislain Aubin; Stanimir Kambarev; Pascale Bémer; Paul A Lawson; Stéphane Corvec
Journal:  Genome Announc       Date:  2016-08-11

8.  Which is the best treatment for prosthetic joint infections due to Propionibacterium acnes: need for further biofilm in vitro and experimental foreign-body in vivo studies?

Authors:  Stéphane Corvec; Guillaume G Aubin; Roger Bayston; Waheed Ashraf
Journal:  Acta Orthop       Date:  2016-04-04       Impact factor: 3.717

9.  Bactericidal efficacy of hydrogen peroxide on Cutibacterium acnes.

Authors:  P Hernandez; B Sager; A Fa; T Liang; C Lozano; M Khazzam
Journal:  Bone Joint Res       Date:  2019-02-02       Impact factor: 5.853
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.